Bills and Resolutions Drug Quality and Security Act along with other FDA Bills and Resolutions--

Congressional Record Index (2013)]
[From the U.S. Government Printing Office, www.gpo.gov]



FEDERAL FOOD, DRUG, AND COSMETIC ACT

  Amendments
      Dept. of HHS: reauthorize certain programs to protect against 
        pandemics and attacks from chemical, biological, radiological, 
        and nuclear weapons (H.R. 307), S948 [27FE], H823 [4MR]
      FDA: strengthen regulation of compounding drugs by pharmacies 
        (S. 959), S6080, S6081 [30JY]
      ------strengthen regulation of human drug compounding and drug 
        supply chain security (H.R. 3204), S7683, S7684 [30OC]
  Bills and resolutions
      Dept. of HHS: establish single, front-of-package labeling system 
        for all foods required to bear nutrition labeling and 
        eliminate deceptive claims and update existing nutrition 
        labels (see S. 1653), S7829 [5NO] (see H.R. 3147), H5766 
        [19SE]
      ------grant provisional approval to fast-tracked drugs used in 
        therapies and treatments for life-threatening diseases (see 
        H.R. 2090), H2910 [22MY]
      ------prevent abuse of dextromethorphan by restricting over-the-
        counter sales and bulk distribution (see S. 644), S2146 [21MR]
      ------reauthorize certain programs to protect against pandemics 
        and attacks from chemical, biological, radiological, and 
        nuclear weapons (see S. 242), S519 [7FE] (see H.R. 307), H176 
        [18JA]
      ------submit annual reports on assessment and collection of 
        certain tobacco user fees (see H.R. 389), H280 [23JA]
      Drugs: reschedule marijuana under the Controlled Substances Act 
        and allow for medicinal use of marijuana in accordance with 
        State laws (see H.R. 689), H545 [14FE]
      FDA: enhance reporting requirements pertaining to use of 
        antimicrobial drugs in food animals (see H.R. 820), H658 
        [26FE]
      ------ensure safe use of cosmetics (see H.R. 1385), H1824 [21MR]
      ------ensure valid generic drugs may enter the market (see S. 
        504), S1269 [7MR]
      ------improve ability to study use of antimicrobial drugs in 
        food-producing animals (see S. 895), S3256 [8MY]
      ------improve safety of dietary supplements by requiring 
        manufacturers to register supplement products with the FDA and 
        amending labeling requirements (see S. 1425), S6206 [1AU]
      ------permit the sale of, and access to, ``research use only'' 
        products in diagnostic tests (see H.R. 3005), H5397 [2AU]
      ------prohibit use of Federal money for any media advertisement, 
        campaign, or publicity against the use of a food or beverage 
        lawfully marketed under the Federal Food, Drug, and Cosmetic 
        Act (see H.R. 1572), H2026 [15AP]
      ------prohibit wholesalers from purchasing prescription drugs 
        from pharmacies and enhance information and transparency of 
        drug wholesalers engaged in interstate commerce (see H.R. 
        1958), H2602 [14MY]
      ------provide for the regulation of medical software (see H.R. 
        3303), H6675 [22OC]
      ------provide incentives for the development of new combination 
        drugs (see H.R. 2985), H5396 [2AU]
      ------reauthorize user fee programs relating to generic new 
        animal drugs (see H.R. 1408), H1856 [9AP]
      ------reauthorize user fee programs relating to new animal drugs 
        (see H.R. 1407), H1856 [9AP]
      ------reauthorize user fee programs relating to new animal drugs 
        and generic new animal drugs (see S. 622), S2026 [20MR]
      ------require labeling of genetically-engineered fish (see S. 
        248), S519 [7FE] (see H.R. 584), H413 [6FE]
      ------require that genetically engineered food and foods that 
        contain genetically engineered ingredients be labeled 
        accordingly (see S. 809), S2960 [24AP] (see H.R. 1699), H2297 
        [24AP]
      ------require the label of drugs to contain a parenthetical 
        statement identifying the source of any ingredient 
        constituting or derived from a grain or starch-containing 
        ingredient (see H.R. 2003), H2654 [15MY]
      ------strengthen and secure the pharmaceutical distribution 
        supply chain to protect consumers from counterfeit 
        pharmaceuticals (see S. 957), S3531 [15MY] (see H.R. 1919), 
        H2567 [9MY]
      ------strengthen regulation of compounding drugs by pharmacies 
        (see S. 959), S3531 [15MY] (see H.R. 2186), H2954 [23MY] (see 
        H.R. 3019), H5397 [2AU] (see H.R. 3089), H5546 [12SE]
      ------strengthen regulation of human drug compounding and drug 
        supply chain security (see H.R. 3204), H5921 [27SE]
      Food: amend inspection laws to notify consumers of products 
        produced from crops, livestock, or poultry raised on sewage 
        sludge-treated land (see H.R. 213), H52 [4JA]
      Food industry: improve and clarify certain disclosure 
        requirements for restaurants, similar retail food 
        establishments, and vending machines (see H.R. 1249), H1629 
        [19MR]
      Health: incentivize the development of abuse-deterrent drugs 
        (see H.R. 486), H342 [4FE]
      Pharmaceuticals: preserve effectiveness of medically important 
        antimicrobials used in treatment of human and animal diseases 
        (see S. 1256), S5498 [27JN] (see H.R. 1150), H1425 [14MR]
      Product safety: ban use of bisphenol A in food and beverage 
        containers (see H.R. 2248), H3095 [4JN]
      ------ban use of bisphenol A in food and beverage containers for 
        children, baby food, and infant formula and regulate its use 
        in other food containers (see S. 1124), S4058 [10JN]
      ------prohibit the sale of infant formula after the expiration 
        date on the product (see H.R. 2306), H3256 [10JN]
      Tobacco products: clarify FDA jurisdiction over certain tobacco 
        products and protect jobs and small businesses involved in the 
        sale, manufacturing, and distribution of cigars (see S. 772), 
        S2798 [18AP] (see H.R. 792), H595 [15FE]
  Letters
      Dept. of HHS programs to protect against pandemics and attacks 
        from chemical, biological, radiological, and nuclear weapons 
        reauthorization: Alliance for Biosecurity, H833 [4MR]
      ------James C. Greenwood, Biotechnology Industry Organization, 
        H833 [4MR]
      ------Stephanie Silverman, Roundtable on Critical Care Policy 
        (organization), H834 [4MR]
      ------Thomas K. McInerny, American Academy of Pediatrics, H833 
        [4MR]
      ------several health organizations, H199 [22JA]
      ------several public health organizations, H834 [4MR]
      Safeguarding America's Pharmaceuticals Act: several 
        organizations, H2982, H2983 [3JN]
      ------Stanley C. Weisser, California State Board of Pharmacy, 
        H2981 [3JN]
  Remarks in House
      Dept. of HHS: reauthorize certain programs to protect against 
        pandemics and attacks from chemical, biological, radiological, 
        and nuclear weapons (H.R. 307), H187-H201 [22JA]
      ------reauthorize certain programs to protect against pandemics 
        and attacks from chemical, biological, radiological, and 
        nuclear weapons (H.R. 307), Senate amendment, H823-H836 [4MR], 
        E255 [7MR]
      Drugs: reschedule marijuana under the Controlled Substances Act 
        and allow for medicinal use of marijuana in accordance with 
        State laws (H.R. 689), E150 [14FE]
      FDA: enhance reporting requirements pertaining to use of 
        antimicrobial drugs in food animals (H.R. 820), H2991 [3JN]
      ------prohibit wholesalers from purchasing prescription drugs 
        from pharmacies and enhance information and transparency of 
        drug wholesalers engaged in interstate commerce, E784 [4JN]
      ------reauthorize user fee programs relating to new animal drugs 
        and generic new animal drugs (S. 622), H2984-H2993 [3JN], E829 
        [10JN]
      ------require that genetically engineered food and foods that 
        contain genetically engineered ingredients be labeled 
        accordingly (H.R. 1699), H2258 [24AP]
      ------strengthen and secure the pharmaceutical distribution 
        supply chain to protect consumers from counterfeit 
        pharmaceuticals, H5961, H5962, H5965 [28SE]
      ------strengthen and secure the pharmaceutical distribution 
        supply chain to protect consumers from counterfeit 
        pharmaceuticals (H.R. 1919), H2968-H2984 [3JN], E784, E796 
        [4JN], E883 [17JN]
      ------strengthen and secure the pharmaceutical distribution 
        supply chain to protect consumers from counterfeit 
        pharmaceuticals (S. 957), H2979 [3JN]
      ------strengthen regulation of compounding drugs by pharmacies, 
        H5961, H5962, H5965 [28SE]
      ------strengthen regulation of compounding drugs by pharmacies 
        (H.R. 3019), E1223 [2AU]
      ------strengthen regulation of human drug compounding and drug 
        supply chain security (H.R. 3204), H5946-H5965 [28SE]
      Orphan Drug Act: anniversary, E13 [4JA]
      Pharmaceuticals: preserve effectiveness of medically important 
        antimicrobials used in treatment of human and animal diseases 
        (H.R. 1150), H2991, H2992 [3JN], H6623 [16OC], E299 [14MR]
      Product safety: ban use of bisphenol A in food and beverage 
        containers (H.R. 2248), H6660 [22OC]
  Remarks in Senate
      Dept. of HHS: reauthorize certain programs to protect against 
        pandemics and attacks from chemical, biological, radiological, 
        and nuclear weapons (H.R. 307), S948-S957 [27FE], S1123 [5MR]
      FDA: allow fast track approval of certain orphan drugs, S3002 
        [25AP]
      ------improve safety of dietary supplements by requiring 
        manufacturers to register supplement products with the FDA and 
        amending labeling requirements, S1920 [19MR], S6041 [30JY]
      ------reauthorize user fee programs relating to new animal drugs 
        and generic new animal drugs (S. 622), S3275 [8MY]
      ------require labeling of genetically-engineered fish, S2279 
        [22MR]
      ------strengthen regulation of human drug compounding and drug 
        supply chain security (H.R. 3204), S7800 [4NO], S7802 [5NO]
      GAO: report on FDA Adverse Event Reporting System for dietary 
        supplements, S1920 [19MR]
      Pharmaceuticals: preserve effectiveness of medically important 
        antimicrobials used in treatment of human and animal diseases 
        (S. 1256), S5503 [27JN]
      Product safety: ban use of bisphenol A in food and beverage 
        containers for children, baby food, and infant formula and 
        regulate its use in other food containers (S. 1124), S4059 
        [10JN]
  Reports filed
      Dept. of HHS Programs To Protect Against Pandemics and Attacks 
        From Chemical, Biological, Radiological, and Nuclear Weapons 
        Reauthorization: Committee on Health, Education, Labor, and 
        Pensions (Senate) (H.R. 307), S771 [14FE]
      FDA User Fee Programs Relating to New Animal Drugs and Generic 
        New Animal Drugs Reauthorization: Committee on Health, 
        Education, Labor, and Pensions (Senate) (S. 622), S2025 [20MR]
      FDA User Fee Programs Relating to New Animal Drugs 
        Reauthorization: Committee on Energy and Commerce (House) 
        (H.R. 1407) (H. Rept. 113-188), H5395 [2AU]
      Pharmaceutical Compounding Quality and Accountability Act: 
        Committee on Health, Education, Labor, and Pensions (Senate) 
        (S. 959), S4673 [19JN]
      Safeguarding America's Pharmaceuticals Act: Committee on Energy 
        and Commerce (House) (H.R. 1919) (H. Rept. 113-93), H3014 
        [3JN]
  Statements
      Safeguarding America's Pharmaceuticals Act: Pew Charitable 
        Trust, H2981 [3JN]
  Texts of
      H.R. 307, Dept. of HHS programs to protect against pandemics and 
        attacks from chemical, biological, radiological, and nuclear 
        weapons reauthorization, S948-S957 [27FE], H187-H197 [22JA]
      H.R. 1911, Safeguarding America's Pharmaceuticals Act, H2969-
        H2978 [3JN]
      H.R. 3204, Drug Quality and Security Act, H5946-H5960 [28SE]
      S. 622, FDA reauthorization of user fee programs relating to new 
        animal drugs and generic new animal drugs, S3275-S3282 [8MY]
      S. 622, FDA user fee programs relating to new animal drugs and 
        generic new animal drugs reauthorization, H2984-H2991 [3JN]
      S. 1425, Dietary Supplement Labeling Act, S6216 [1AU]
source found here